Citadel Advisors’s AXS Cannabis ETF THCX Stock Holding History

Citadel Advisors’s Portfolio THCX Stock Details THCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,088	Closed	-$18.4K	–	15789
2023 Q4	$18.4K	Buy	+1,088	New	+$18K	﹤0.01%	12690
2023 Q2	–	Sell	-1,178	Closed	-$25.3K	–	15520
2023 Q1	$25.3K	Buy	+1,178	New	+$29.5K	﹤0.01%	12879
2019 Q4	–	Sell	-1,471	Closed	-$243K	–	9926
2019 Q3	$243K	Buy	+1,471	New	+$312K	﹤0.01%	7881

Citadel Advisors's THCX Position: Q1 2024 in Review

Citadel Advisors sold out of AXS Cannabis ETF (THCX) in Q1 2024, closing a stake of 1,088 shares — an estimated $18.4K sold.

Citadel Advisors first reported a position in THCX in Q3 2019 and held it in 3 quarters. The position peaked at $243K in Q3 2019. 0 funds tracked by Wall St. Rank hold THCX as of Q1 2024.

Citadel Advisors reported no remaining AXS Cannabis ETF position as of Q1 2024 after selling out during the quarter.
Citadel Advisors sold 1,088 AXS Cannabis ETF shares in Q1 2024, an estimated $18.4K.
Citadel Advisors first reported a position in AXS Cannabis ETF in Q3 2019 and held it in 3 quarters.
Citadel Advisors's AXS Cannabis ETF position peaked at $243K in Q3 2019.
0 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.